ALDH1A3 antibody [N2C2], Internal
GTX110784
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetALDH1A3
Overview
- SupplierGeneTex
- Product NameALDH1A3 antibody [N2C2], Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.1 mg/ml
- ConjugateUnconjugated
- Gene ID220
- Target nameALDH1A3
- Target descriptionaldehyde dehydrogenase 1 family member A3
- Target synonymsALDH1A6, ALDH6, MCOP8, RALDH3, retinaldehyde dehydrogenase 3, acetaldehyde dehydrogenase 6, aldehyde dehydrogenase 6
- HostRabbit
- IsotypeIgG
- Protein IDP47895
- Protein NameRetinaldehyde dehydrogenase 3
- Scientific DescriptionAldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. The enzyme encoded by this gene uses retinal as a substrate, either in a free or cellular retinol-binding protein form. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Chung SY, Hung YP, Pan YR, et al. Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway. Biomedicines. 2021,9(8). doi: 10.3390/biomedicines9080885Read this paper
- Park JW, Jung KH, Byun Y, et al. ATP-binding Cassette Transporters Substantially Reduce Estimates of ALDH-positive Cancer Cells based on Aldefluor and AldeRed588 Assays. Sci Rep. 2019,9(1):6462. doi: 10.1038/s41598-019-42954-9Read this paper
- Chen MH, Weng JJ, Cheng CT, et al. ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients. Clin Cancer Res. 2016,22(16):4225-35. doi: 10.1158/1078-0432.CCR-15-1800Read this paper





